87 related articles for article (PubMed ID: 21414972)
1. Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Kupper MB; Hoffmann K; Eitner F; Ostendorf T; Floege J
Nephrol Dial Transplant; 2011 Oct; 26(10):3131-43. PubMed ID: 21414972
[TBL] [Abstract][Full Text] [Related]
2. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
[TBL] [Abstract][Full Text] [Related]
4. Receptor-independent intracellular radical scavenging activity of an angiotensin II receptor blocker.
Shao J; Nangaku M; Inagi R; Kato H; Miyata T; Matsusaka T; Noiri E; Fujita T
J Hypertens; 2007 Aug; 25(8):1643-9. PubMed ID: 17620961
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
Toxicology; 2011 Jan; 279(1-3):91-9. PubMed ID: 20888384
[TBL] [Abstract][Full Text] [Related]
7. Real-time monitoring of the effects of telmisartan on angiotensin II-induced mechanical changes in live mesangial cells using atomic force microscopy.
Jeong KH; Lee TW; Ihm CG; Moon JY; Lee GJ; Park HK; Lee SH
Kidney Blood Press Res; 2012; 35(6):573-82. PubMed ID: 22890312
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
Benson SC; Iguchi R; Ho CI; Yamamoto K; Kurtz TW
J Hypertens; 2008 May; 26(5):973-80. PubMed ID: 18398340
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
Kaschina E; Schrader F; Sommerfeld M; Kemnitz UR; Grzesiak A; Krikov M; Unger T
J Hypertens; 2008 Dec; 26(12):2361-73. PubMed ID: 19008714
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
Pelliccia F; Pasceri V; Cianfrocca C; Vitale C; Speciale G; Gaudio C; Rosano GM; Mercuro G
Atherosclerosis; 2010 Jun; 210(2):510-5. PubMed ID: 20044087
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats.
Satoh M; Haruna Y; Fujimoto S; Sasaki T; Kashihara N
Hypertens Res; 2010 Feb; 33(2):135-42. PubMed ID: 19927153
[TBL] [Abstract][Full Text] [Related]
12. Reduction of proteinuria with angiotensin receptor blockers.
Galle J
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S36-43. PubMed ID: 18580865
[TBL] [Abstract][Full Text] [Related]
13. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Harada N; Shimozawa N; Okajima K
Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan ameliorates germ cell toxicity in the STZ-induced diabetic rat: studies on possible molecular mechanisms.
Kushwaha S; Jena GB
Mutat Res; 2013 Jul; 755(1):11-23. PubMed ID: 23648321
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
16. Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats.
Arozal W; Watanabe K; Veeraveedu PT; Thandavarayan RA; Harima M; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
J Pharm Pharmacol; 2010 Dec; 62(12):1776-83. PubMed ID: 21054405
[TBL] [Abstract][Full Text] [Related]
17. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage.
Jung KH; Chu K; Lee ST; Kim SJ; Song EC; Kim EH; Park DK; Sinn DI; Kim JM; Kim M; Roh JK
J Pharmacol Exp Ther; 2007 Sep; 322(3):1051-8. PubMed ID: 17538008
[TBL] [Abstract][Full Text] [Related]
18. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J
Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]